» Articles » PMID: 11556847

Cell Surface Antigens in Renal Tumour Cells: Detection by Immunoluminescence and Enzymatic Analysis

Overview
Journal Br J Cancer
Specialty Oncology
Date 2001 Sep 15
PMID 11556847
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Two renal cell carcinoma cell lines (49RC 43STR and 75RC 2STR) were characterized by detection of the cell surface proteins: CD44(var), intercellular adhesion molecule-1 (ICAM-1), urokinase-type plasminogen activator (uPA) and its receptor and aminopeptidase N (APN). To detect their localization the immunoluminescent technique was used. In addition, the enzyme activity of uPA and APN was investigated in cell suspensions as well as in monolayers. The latter procedure was more advantageous since the additional use of HPLC permits a single registration of the fluorescent hydrolysis-product AMC (7-amino-4-methylcoumarin) without interference by cellular autofluorescence or non-reacted fluorescent substrate. Unlike 75RC 2STR, the cell line 49RC 43STR expressed high levels of uPA and APN. Contrary to that the cell line 75RC 2STR expressed high levels of ICAM-1 and CD44(v6), whereas 49RC 43STR showed a low level of ICAM-1 and no distinct light signal with anti-CD44(v6). The uPA activity was measured directly as well as indirectly (via plasmin) with the substrate Z-Gly-Gly-Arg-AMC. Both activator and plasmin activity were inhibited by D-Val-Phe-Lys-CMK and phenylmethylsulfonyl fluoride. The anti-catalytic antibody to uPA and that to uPA receptor were found to be inhibiting the uPA activity in a concentration-dependent manner. APN activity was assayed using alanine-p-nitroanilide. Peptidase activity was effectively inhibited by 1,10-phenanthroline and partly inhibited by ethylenediamine-tetraacetic acid.

Citing Articles

Detection of in vivo enzyme activity with CatalyCEST MRI.

Yoo B, Sheth V, Howison C, Douglas M, Pineda C, Maine E Magn Reson Med. 2013; 71(3):1221-30.

PMID: 23640714 PMC: 3742626. DOI: 10.1002/mrm.24763.


An amine-derivatized, DOTA-loaded polymeric support for Fmoc Solid Phase Peptide Synthesis.

Yoo B, Sheth V, Pagel M Tetrahedron Lett. 2010; 50(31):4459-4462.

PMID: 20161272 PMC: 2702766. DOI: 10.1016/j.tetlet.2009.05.061.

References
1.
Zimmerman M, Quigley J, ASHE B, Dorn C, Goldfarb R, Troll W . Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles. Proc Natl Acad Sci U S A. 1978; 75(2):750-3. PMC: 411334. DOI: 10.1073/pnas.75.2.750. View

2.
Gohring B, Holzhausen H, Meye A, Heynemann H, Rebmann U, Langner J . Endopeptidase 24.11/CD10 is down-regulated in renal cell cancer. Int J Mol Med. 1998; 2(4):409-14. DOI: 10.3892/ijmm.2.4.409. View

3.
Cubellis M, Wun T, Blasi F . Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J. 1990; 9(4):1079-85. PMC: 551782. DOI: 10.1002/j.1460-2075.1990.tb08213.x. View

4.
Meissauer A, Kramer M, Schirrmacher V, Brunner G . Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro. Exp Cell Res. 1992; 199(2):179-90. DOI: 10.1016/0014-4827(92)90423-6. View

5.
Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T . Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer. 1993; 54(1):137-43. PMC: 7165932. DOI: 10.1002/ijc.2910540122. View